You are using an outdated browser. Please upgrade your browser to improve your experience.
Become a Fellow
ACP offers a number of resources to help members make sense of the MOC requirements and earn points.
Understanding MOC Requirements
Earn MOC points
The most comprehensive meeting in Internal Medicine.
April 11-13, 2019
Internal Medicine Meeting 2019
Prepare for the Certification and Maintenance of Certification (MOC)
Exam with an ACP review course.
Board Certification Review Courses
MOC Exam Prep Courses
Treating a patient? Researching a topic? Get answers now.
Visit AnnalsLearn More
Visit MKSAP 17 Learn More
Visit DynaMed Plus
Ensure payment and avoid policy violations. Plus, new resources to help you navigate the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
Access helpful forms developed by a variety of sources for patient charts, logs, information sheets, office signs, and use by practice administration.
ACP advocates on behalf on internists and their patients on a number of timely issues. Learn about where ACP stands on the following areas:
© Copyright 2018 American College of Physicians. All Rights Reserved. 190 North Independence Mall West, Philadelphia, PA 19106-1572
Toll Free: (800) 523.1546 · Local: (215) 351.2400
(Boston, April 11, 2016)—“The rising cost of prescription drugs is an overarching concern that is having a real impact on our patients,” said Elisa Choi, MD, American College of Physicians Massachusetts Governor’s Council Treasurer, testifying today before the state legislature’s Joint Committee on Health Care Financing.
Dr. Choi told the committee in the hearing on An Act to Promote Transparency and Cost Control of Pharmaceutical Prices (S. 1048), that the detrimental effect on patients can cause them to forgo filling important prescriptions or not taking drugs on the schedule that they are prescribed.
In her testimony, Dr. Choi pointed to the portions of the legislation that are in line with the American College of Physicians’ policy on transparency in prescription drug pricing. The policy supports transparency in the pricing, cost and comparative value of all pharmaceutical products.
Dr. Choi pointed out to the committee the recent example of a federal congressional investigation into the pricing behind Gilead’s groundbreaking Hepatitis C drugs. The investigation found that Gilead’s pricing strategy was focused on maximizing revenue—even though the company’s own analysis showed that a lower price would allow more patients to be treated.
The transparency provisions of the bill before the Massachusetts legislature are key components to achieving a better understanding of how companies factor development costs into the price of prescription drugs. Importantly, the bill says pharmaceutical manufacturers should disclose:
“ACP believes that transparency initiatives are important stepping stones in an effort to repair the broken prescription drug market and reining in the unsustainable growth in prescription drug pricing,” concluded Dr. Choi. “The transparency provisions in this bill would serve to better inform future efforts around prescription drug pricing.”
The American College of Physicians is the largest medical specialty organization and the second-largest physician group in the United States. ACP members include 143,000 internal medicine physicians (internists), related subspecialists, and medical students. Internal medicine physicians are specialists who apply scientific knowledge and clinical expertise to the diagnosis, treatment, and compassionate care of adults across the spectrum from health to complex illness. Follow ACP on Twitter and Facebook.
Jacquelyn Blaser, (202) 261-4572